Empower@Home: Hybrid Effectiveness-Implementation Randomized Controlled Trial (RCT)

Recruiting now · Not applicable

Conditions studied: Depression

In brief

This study is a randomized Type I hybrid effectiveness-implementation trial aimed at evaluating the effectiveness of Empower@Home, an internet-delivered cognitive-behavioral therapy (CBT) program supported by aging service providers, in comparison to enhanced usual care for homebound older adults with depressive symptoms. A total of 256 participants will be randomly assigned to either the treatment group (Empower@Home) or the control group (enhanced usual care) in a 1:1 allocation ratio, with randomization stratified by participating agencies. The primary aim of this study is to determine the clinical effectiveness of the Empower@Home program. It is hypothesized that participants receiving Empower@Home will show greater improvements in depressive symptoms at 12, 24, and 36 weeks after entering the study compared to those receiving enhanced usual care. Additionally, treatment moderators will be explored and a cost-effectiveness analysis will be conducted to assess the economic viability of the intervention. The second aim is to investigate the mechanisms of change facilitated by the intervention using a mixed-methods approach. Causal mediation analysis will examine whether the acquisition of CBT skills, reduction in cognitive distortions, and increased behavioral activation, as well as participant engagement and the therapeutic alliance with the coach, mediate the treatment effects. Qualitative interviews with participants will be conducted to provide deeper insights into these mechanisms and enhance the interpretation of the mediation analysis. The third aim focuses on evaluating the implementation process using the updated Consolidated Framework for Implementation Research (CFIR). This will involve a qualitative process evaluation to identify barriers and facilitators to the implementation of Empower@Home, drawing on perspectives from multiple stakeholders.

Key facts

Study ID: NCT06584422
Run by: University of Michigan
People needed: 256
Starts: 2024-10-01
Expected to finish: 2029-07-01
Last updated by the study team: 2025-11-21

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

(1) be receiving or eligible to receive services at the recruitment sites
(2) read and speak English
(3) be at least 50 years old
(4) have at least moderate depressive symptoms at screening (≥ 8 on the Patient Health Questionnaire-9 [PHQ-9]).
(5) Participants who are NOT currently receiving outside therapy must agree NOT to start outside therapy during study participation. Participants who are currently receiving outside therapy must agree NOT to increase their outside therapy frequency during study participation.

You may not qualify if…

(1) probable dementia based on the Blessed Orientation and Memory Scale.
(2) moderate or high risk of suicide based on the 6-item Columbia-Suicide Severity Rating Scale
(3) a terminal illness with less than six months to live or unstable physical health conditions based on self-report
(4) a diagnosis of a psychotic disorder like schizophrenia or bipolar disorder based on self-report and medical chart review
(5) severe vision impairment based on self-report (i.e., legally blind)
(6) current substance use disorders or receiving substance use treatment.
(7) currently receiving outside therapy more frequently than once a month or have started a new therapy treatment less than 3 months ago

Where it is running

University of Michigan — Ann Arbor, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.